5 research outputs found

    Case report: maternal mosaicism resulting in inheritance of a novel GATA6 mutation causing pancreatic agenesis and neonatal diabetes mellitus.

    Get PDF
    Haploinsufficiency of the GATA6 transcription factor gene was recently found to be the most common cause of pancreatic agenesis, a rare cause of neonatal diabetes mellitus. Although most cases are de novo, we describe three siblings with inherited GATA6 haploinsufficiency and the rare finding of parental mosaicism.This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site

    Fascinating and forgotten: the conservation status of marine elapid snakes

    No full text
    An assessment of marine elapid snakes found 9% of marine elapids are threatened with extinction, and an additional 6% are Near Threatened. A large portion (34%) is Data Deficient. An analysis of distributions revealed the greatest species diversity is found in Southeast Asia and northern Australia. Three of the seven threatened species occur at Ashmore and Hibernia Reefs in the Timor Sea, while the remaining threatened taxa occur in the Philippines, Niue, and Solomon Islands. The majority of Data Deficient species are found in Southeast Asia. Threats to marine snakes include loss of coral reefs and coastal habitat, incidental bycatch in fisheries, as well as fisheries that target snakes for leather. The presence of two Critically Endangered and one Endangered species in the Timor Sea suggests the area is of particular conservation concern. More rigorous, long-term monitoring of populations is needed to evaluate the success of “conservation measures” for marine snake species, provide scientifically based guidance for determining harvest quotas, and to assess the populations of many Data Deficient species.Cristiane T. Elfes, Suzanne R. Livingstone, Amanda Lane, Vimoksalehi Lukosche, Kate L. Sanders, Anthony J. Courtney, Joey L. Gatus, Michael Guinea, Aaron S. Lobo, David Milton, Arne R. Rasmussen, Mark Read, Mahree-Dee White, Jonnell Sanciangco, Angel Alcala, Harold Heatwole, Daryl R. Karns, Jeffrey A. Seminoff, Harold K. Voris, Kent E. Carpenter, John C. Murph

    Chemopreventive potential of curcumin in prostate cancer

    No full text
    The long latency and high incidence of prostate carcinogenesis provides the opportunity to intervene with chemoprevention in order to prevent or eradicate prostate malignancies. We present here an overview of the chemopreventive potential of curcumin (diferuloylmethane), a well-known natural compound that exhibits therapeutic promise for prostate cancer. In fact, it interferes with prostate cancer proliferation and metastasis development through the down-regulation of androgen receptor and epidermal growth factor receptor, but also through the induction of cell cycle arrest. It regulates the inflammatory response through the inhibition of pro-inflammatory mediators and the NF-κB signaling pathway. These results are consistent with this compound’s ability to up-induce pro-apoptotic proteins and to down-regulate the anti-apoptotic counterparts. Alone or in combination with TRAIL-mediated immunotherapy or radiotherapy, curcumin is also reported to be a good inducer of prostate cancer cell death by apoptosis. Curcumin appears thus as a non-toxic alternative for prostate cancer prevention, treatment or co-treatment
    corecore